gp91-phox antibody | knockout validation | Santa Cruz sc-130543

This is a knockout-validated antibody summary, based on the publication "Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

gp91-phox antibody | knockout validation | Santa Cruz sc-130543 figure 1
Figure 1. gp91phox expression in purified BM neutrophils from control, Eros−/−, and gp91phox−/− neutrophils. Data are representative of at least three independent experiments. From [1].
Antibody information

Mouse monoclonal IgG1 (kappa light chain)

Company: Santa Cruz

Antibody: gp91-phox

Catalog number: sc-130543

Summary: Mouse monoclonal IgG1 (kappa light chain) against human gp91-phox, with epitope mapping to amino acids 383-390. Recommended for detection of gp91-phox of mouse, rat and human origin by western blot, immunoprecipitation, immunofluorescence and immunohistochemistry (paraffin). Also recommended for detection of ERp57, Mox1, Nox3 and Nox4.

Validation Method

Western blot

Sample

Control and Eros−/− murine bone marrow (BM) neutrophils. Cells were lysed using a low-salt lysis buffer extracts (150 mM NaCl and 0.1% NP-40).

Blocking agent

5% milk nonfat dry milk powder dissolved in Tris-HCL buffered saline (pH 8.0) containing 0.1% (wt/vol) Tween-20 for 1 h at room temperature.

Primary incubation

Antibody was diluted in Tris-HCL buffered saline (pH 8.0) containing 0.1% (wt/ vol) Tween 20 and incubated at 4°C overnight.

Detection

ECL Prime reagents (GE Healthcare) and Lumigen TMA-6.

Clone note

The same clone (54.1) is sold as Santa Cruz Biotechnology sc-130543; ImmuQuest IQ439, IQ439HRP; Invitrogen MA5-18052.

References
  1. Thomas D, Clare S, Sowerby J, Pardo M, Juss J, Goulding D, et al. Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity.. J Exp Med. 2017;214:1111-1128 pubmed publisher